Gunnar F. Kaufmann's most recent trade in Oncternal Therapeutics Inc was a trade of 210,000 Stock Option done . Disclosure was reported to the exchange on Feb. 21, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Oncternal Therapeutics Inc | Gunnar F. Kaufmann | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2023 | 210,000 | 210,000 | - | - | Stock Option | |
| Oncternal Therapeutics Inc | Gunnar F. Kaufmann | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.02 per share. | 03 Jan 2023 | 6,266 | 66,726 (0%) | 0% | 1.0 | 6,391 | Common Stock |
| Oncternal Therapeutics Inc | Gunnar F. Kaufmann | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2022 | 43,125 | 72,992 (0%) | 0% | 0 | Common Stock | |
| Oncternal Therapeutics Inc | Gunnar F. Kaufmann | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2022 | 28,750 | 28,750 | - | - | Stock Option | |
| Oncternal Therapeutics Inc | Gunnar F. Kaufmann | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2022 | 162,457 | 162,457 | - | - | Stock Option | |
| Oncternal Therapeutics Inc | Gunnar F. Kaufmann | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 29,867 | 29,867 (0%) | 0% | 0 | Common Stock | |
| Oncternal Therapeutics Inc | Gunnar F. Kaufmann | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 253,000 | 253,000 | - | - | Stock Option |